Reports for GE HEALTHCARE CANADA INC
Company Name
GE HEALTHCARE CANADA INC
Totals |
||
Shortage reports |
96 |
|
Actual shortage: | 0 (0%) | |
Anticipated shortage: | 1 (1%) | |
Avoided shortage: | 6 (6%) | |
Resolved: | 89 (93%) | |
Discontinuation Reports |
5 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 5 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
0 (0%) |
|
Overdue reports |
0 (0%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2024-09-16 | 2024-09-21 | 237683 |
OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2024-09-17 | 2024-09-28 | 237809 |
OMNIPAQUE 240 | 518MG | SOLUTION | Anticipated shortage | 2025-01-24 | 2025-02-05 | 248506 |
OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2021-08-18 | 2021-08-25 | 144299 |
OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2022-04-01 | 2022-04-19 | 157813 |
OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2022-05-12 | 2023-03-01 | 160389 |
OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-07 | 160534 |
OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-17 | 160537 |
OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-05 | 160540 |
OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-17 | 160562 |
OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2024-01-26 | 2024-02-15 | 217411 |
OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2024-01-26 | 2024-02-24 | 217417 |
OMNIPAQUE 350 | 755MG | SOLUTION | Resolved | 2021-08-06 | 2021-08-13 | 143789 |
OMNIPAQUE 350 | 755MG | SOLUTION | Resolved | 2022-04-11 | 2022-04-22 | 158491 |
OMNIPAQUE 350 | 755MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-17 | 160543 |
OMNIPAQUE 350 | 755MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-05 | 160546 |
OMNIPAQUE 350 | 755MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-05 | 160549 |
OMNIPAQUE 350 | 755MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-05 | 160552 |
OMNIPAQUE 350 | 755MG | SOLUTION | Avoided shortage | 2024-01-30 | 2024-02-14 | 217731 |
OMNISCAN | 287MG | SOLUTION | Resolved | 2019-09-10 | 2019-09-17 | 93472 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
Metastron | 37 MBq/mL | Solution | Discontinued | 2018-10-12 | 2019-02-01 | 63929 |
OMNIPAQUE 180 | 388MG | SOLUTION | Discontinued | 2023-01-31 | 2023-02-22 | 182757 |
OMNIPAQUE 240 | 518MG | SOLUTION | Discontinued | 2023-01-31 | 2023-03-18 | 182760 |
OMNISCAN | 287MG | SOLUTION | Discontinued | 2023-01-31 | 2023-03-25 | 182742 |
THALLOUS CHLORIDE TI 201 INJECTION | 37MBq | SOLUTION | Discontinued | 2020-12-04 | 2021-06-05 | 129592 |
Showing 1 to 5 of 5